Evolus (EOLS) Invested Capital (2017 - 2026)
Evolus (EOLS) reported Invested Capital of $119.09 million for Q3 2026, up 1.8% from $117.02 million a year earlier but down 5.4% from the prior quarter.
Powered by 
Analysis
Evolus (EOLS) Invested Capital (2017 - 2026) Analysis & Trends
For FY2025, Evolus posted Invested Capital of $122.99 million, down 3.2% from FY2024.
- Invested Capital has a five-year compound annual growth rate of 43.1% (FY2020 to FY2025).
- By year, Invested Capital came in at $127.03 million in FY2024 (+27.4%), $99.67 million in FY2023 (+10.3%), $90.38 million in FY2022 (-41.0%) and $153.1 million in FY2021 (+647.0%).
- Five-year quarterly Invested Capital spans a low of $75.73 million in Q3 2023 and a high of $153.1 million in Q4 2021.
- Year over year, Invested Capital gained in three of the last eight quarters, with growth averaging 0.2%.
- The high point for year-over-year Invested Capital in five years was Q4 2021 (growth of 647.0%); the low point was Q1 2023 (a decline of 43.0%).
- Per Business Quant data, the three quarters before Q3 2026 came in at $125.84 million (Q2 2026), $127.63 million (Q1 2026) and $122.99 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 89.77 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 126.18 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 76.32 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 98.72 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 45.14 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 68.36 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 39.27 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 151.97 Bn |
| 10 | Evolus | 450.43 Mn | 259.94 Mn | 50.69 Mn | 119.09 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 119.09 Mn |
| Jun 30, 2026 | 125.84 Mn |
| Mar 31, 2026 | 127.63 Mn |
| Dec 31, 2025 | 122.99 Mn |
| Sep 30, 2025 | 117.02 Mn |
| Jun 30, 2025 | 126.82 Mn |
| Mar 31, 2025 | 115.20 Mn |
| Dec 31, 2024 | 127.03 Mn |
| Sep 30, 2024 | 127.10 Mn |
| Jun 30, 2024 | 140.23 Mn |
| Mar 31, 2024 | 139.08 Mn |
| Dec 31, 2023 | 99.67 Mn |
| Sep 30, 2023 | 75.73 Mn |
| Jun 30, 2023 | 87.87 Mn |
| Mar 31, 2023 | 79.00 Mn |
| Dec 31, 2022 | 90.38 Mn |
| Sep 30, 2022 | 100.93 Mn |
| Jun 30, 2022 | 118.41 Mn |
| Mar 31, 2022 | 138.63 Mn |
| Dec 31, 2021 | 153.10 Mn |
API Access
Evolus Invested Capital API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=invested-capital&ticker=EOLS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "invested-capital", "ticker": "EOLS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=invested-capital&ticker=EOLS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();